Clik here to view.
米国外科学会紀要に掲載：長期の良好な結果は複雑な腹壁ヘルニアの修復におけるGORE BIO-A組織補強材の有効性を実証
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、GORE® BIO-A®組織補強材の使用を評価する長期の前向き多施設試験1の最終結果を発表しました。GORE®...
View ArticleClik here to view.
新发表于《外科年报》的长期有利结果显示GORE BIO-A组织加固材料可有效修复复杂型腹部疝
亚利桑那州弗拉格斯塔夫 (美国商业资讯)–W. L. Gore & Associates, Inc. (Gore)今天发布了一项长期、前瞻性、多中心研究的最终结果，该研究评估生物合成网片GORE® BIO-A® 组织加固材料用于修复伤口污染患者的复杂型腹部疝(CVH)。该研究的主导研究者是克利夫兰诊所的Michael Rosen, MD，研究结果已被接受用于在《外科年报》发表。...
View ArticleClik here to view.
Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. Announce...
NEW BRUNSWICK, N.J. Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. today announced an exclusive license agreement with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ), a...
View ArticleClik here to view.
BioMarker Strategies Announces Issuance of Key Patents in the United States,...
ROCKVILLE, Md. BioMarker Strategies, LLC, today announced that patents covering its core technology have been granted in the United States, Europe, Australia and Hong Kong. “We developed the...
View ArticleClik here to view.
Sinocare Group Closes Acquisition of Nipro Diagnostics
FT. LAUDERDALE, Fla. Nipro Diagnostics announced today that its acquisition by Sinocare Group has been completed. The company also announced that with completion of the acquisition, the company has...
View ArticleClik here to view.
Novocure Submits PMA Partial Amendment Application to Japanese...
ST. HELIER, Jersey Novocure (NASDAQ: NVCR) announced today that it submitted a premarket approval (PMA) partial amendment application to the Japanese Pharmaceuticals and Medical Devices Agency...
View ArticleClik here to view.
Australian Medtech Services Announces Appointment of Eva Reinander as Vice...
SYDNEY Australian Medtech Services (AMS) today announced the appointment of Eva Reinander as Vice President of Asia Pacific. AMS is a strategic planning and concierge service dedicated to assisting...
View ArticleClik here to view.
EYE TECH CARE宣布与中国投资者达成一项重要的注资和伙伴关系协议
法国里昂 (美国商业资讯) — EYE TECH CARE SA是一家开发和营销青光眼无创治疗眼科医疗器材的公司，该公司今天宣布已获得一家中国投资者的新一轮注资。恒松资本将分两轮投资，总金额约为2500万欧元，并将支持EYE TECH CARE的国际扩张。公司将受益于恒松资本在中国的布局，从而推进已经于2015年启动的产品报批。...
View ArticleClik here to view.
Pharm-Olam Continues Global Expansion; Adds Full-Service Coverage in...
HOUSTON Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization to the biopharmaceutical and medical device industries, is proud to announce its...
View ArticleClik here to view.
胸腹主动脉瘤临床研究完成首例植入
亚利桑那州弗拉格斯塔夫 (美国商业资讯) — W. L. Gore & Associates, Inc. (Gore)今天宣布，一项治疗累及腹支血管的主动脉瘤的临床研究完成了美国首例GORE® EXCLUDER®胸腹支内假体的植入。该手术的施术者是明尼苏达州罗切斯特梅奥诊所血管及血管内外科的外科教授Gustavo Oderich,...
View ArticleClik here to view.
胸腹部大動脈瘤の臨床試験で初の植え込みを完了
米アリゾナ州フラッグスタッフ （ビジネスワイヤ） — W. L. Gore & Associates, Inc.（ゴア）は本日、内臓分枝にまたがる大動脈瘤の治療を目的とした臨床試験で、米国初となるGORE® EXCLUDER® Thoracoabdominal Branch...
View ArticleClik here to view.
AtriCure Announces Approval for the AtriClip in Japan
WEST CHESTER, Ohio AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it has received...
View ArticleClik here to view.
AtriCure宣布 AtriClip在日本获得核准
安大略省西切斯特 (美国商业资讯) — AtriCure, Inc. (Nasdaq: ATRC)是房颤(Afib)治疗和左心耳(LAA)处治领域的领先创新者，该公司今天宣布，其AtriClip™产品（包括AtriClip™标准和AtriClip Pro™器械）已获得日本厚生劳动和福祉省(MHLW)的核准。 AtriCure总裁兼首席执行官Mike...
View ArticleClik here to view.
PENTAX Europe GmbH Acquires the Remaining Shares of PENTAX Italia S.r.L. from...
HAMBURG, Germany PENTAX Europe GmbH has acquired the remaining stock of PENTAX Italia S.r.L. from Movi S.p.A. This further investment by PENTAX Europe GmbH into the Italian healthcare market...
View ArticleClik here to view.
Cytori Partner Kerastem Expands US Phase II Trial for Early Stage Hair Loss
SAN DIEGO & TOKYO Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that its licensee Kerastem Technologies, LLC, has expanded STYLE, its US phase II clinical trial investigating early...
View ArticleClik here to view.
Clik here to view.
Kyoto University and Panasonic Developed New Remote Sensing Technology for...
KYOTO & OSAKA, Japan Kyoto University and Panasonic Corporation today announced that they developed a new remote sensing technology for vital signs such as heart rate, heartbeat interval and...
View ArticleClik here to view.
エイトリキュアが日本でのAtriClipの承認を発表
米オハイオ州ウェストチェスター （ビジネスワイヤ） — 心房細動（Afib）治療と左心耳（LAA）管理における一流イノベーター企業のエイトリキュア（Nasdaq: ATRC）は本日、AtriClip™ StandardやAtriClip Pro™の各デバイスを含め、AtriClip™製品の承認を厚生労働省より取得したと発表しました。...
View ArticleClik here to view.
Kyoto University and Panasonic Developed New Remote Sensing Technology for...
KYOTO & OSAKA, Japan Kyoto University and Panasonic Corporation today announced that they developed a new remote sensing technology for vital signs such as heart rate, heartbeat interval and...
View ArticleClik here to view.
京都大学和松下公司开发毫米波雷达生命体征新遥感技术
日本京都和大阪 (美国商业资讯)–京都大学和松下公司今天宣布，他们开发了一项测量心率、心跳间隔等生命体征的新遥感技术。这项技术包括高灵敏扩频雷达和基于特征的心跳间隔估计算法，无需在身体上放置传感器即可测量心率和心跳间隔，并可实现与心电图仪同样的高精度。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View Article